$0.1600
0.00835.47%
Last update: Nov 10, 7:58 PM
Accendra Health Inc
ACHNYSE
Accendra Health fell 93.5% from $2.85 to $0.18, behind the S&P 500's +9.8%. Its worst day was Aug 10 (−50.0%), and its low came Nov 9 at $0.18.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.21 missed the $0.22 estimate on $709.0M revenue (est. $716.8M); FY revenue guidance of $2.5B–$2.6B against the $2.7B consensus.
+5.2% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-0.04 beat the $-0.09 estimate on $627.8M revenue (est. $641.5M); FY revenue guidance of $2.5B–$2.6B against the $2.6B consensus.
+8.7% · S&P 500 +0.2%
EPS of $-0.19 missed the $-0.10 estimate on $613.2M revenue (est. $628.1M); FY revenue guidance of $2.5B–$2.5B against the $2.6B consensus.
−50.0%, the year's worst day · S&P 500 0.0%
Accendra Health shares fell 19.3%, while the S&P 500 fell 0.0%.
−19.3% · S&P 500 0.0%
EPS of $-0.23 missed the $-0.08 estimate on $601.8M revenue (est. $618.5M); FY revenue guidance of $2.5B–$2.5B against the $2.5B consensus.
−31.9% · S&P 500 +0.3%
Where it ended: a close of $0.18 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $-0.15, revenue est. $633.0M).
Nothing in the past 12 months.
All ACH dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ACH and SPY from Benzinga historical bars. Not investment advice.
